|
English
|
正體中文
|
简体中文
|
2831143
|
|
???header.visitor??? :
33142219
???header.onlineuser??? :
1254
???header.sponsordeclaration???
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"doi toshihiko"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
臺大學術典藏 |
2021-07-21T23:21:29Z |
Phase I/Ib clinical trial of sabatolimab, an anti–TIM-3 antibody, alone and in combination with spartalizumab, an anti–PD-1 antibody, in advanced solid tumors
|
Curigliano, Giuseppe; Gelderblom, Hans; Mach, Nicolas; Doi, Toshihiko; Tai, David; Forde, Patrick M.; Sarantopoulos, John; Bedard, Philippe L.; Chia-Chi Lin; Stephen Hodi, F.; Wilgenhof, Sofie; Santoro, Armando; Sabatos-Peyton, Catherine A.; Longmire, Tyler A.; Xyrafas, Alexandros; Sun, Haiying; Gutzwiller, Sabine; Manenti, Luigi; Naing, Aung |
臺大學術典藏 |
2021-05-24T13:07:53Z |
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia
|
Chia-Chi Lin; Doi, Toshihiko; Muro, Kei; Hou, Ming Mo; Esaki, Taito; Hara, Hiroki; Chung, Hyun Cheol; Helwig, Christoph; Dussault, Isabelle; Osada, Motonobu; Kondo, Shunsuke |
Showing items 1-2 of 2 (1 Page(s) Totally) 1 View [10|25|50] records per page
|